Literature DB >> 32747079

Axial psoriatic arthritis: An update for dermatologists.

Alice B Gottlieb1, Joseph F Merola2.   

Abstract

Psoriasis is a chronic, immune-mediated, systemic, inflammatory disorder characterized by skin plaques and, often, nail disease and arthritis that contribute to reduced quality of life. Psoriatic arthritis-a heterogeneous, inflammatory, musculoskeletal disease that can cause permanent damage to both peripheral and axial joints-is the most common comorbidity of psoriasis. Axial disease occurs in 25% to 70% of patients with PsA, with some patients exclusively experiencing axial joint involvement. Early therapeutic intervention is important for preventing permanent joint and spine damage and loss of functionality in these patients. Because skin symptoms associated with psoriasis often precede psoriatic arthritis, dermatologists are uniquely positioned to play an important role in identifying and treating patients with psoriatic arthritis. Proactive screening of patients with all severities of psoriasis for the signs and symptoms of psoriatic arthritis is key to early diagnosis and intervention. In this review, we discuss the clinical presentation, risk factors, and treatment options for psoriatic arthritis with axial involvement, with the aim of helping dermatologists understand the disease and identify patients who might benefit from further assessment, treatment, and/or referral to a rheumatology practice.
Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  axial disease; inflammatory arthritis; inflammatory back pain; psoriasis; psoriatic arthritis

Mesh:

Substances:

Year:  2020        PMID: 32747079     DOI: 10.1016/j.jaad.2020.05.089

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Predictive Value of Monocyte Chemoattractant Protein-1 in the Development of Diastolic Dysfunction in Patients with Psoriatic Arthritis.

Authors:  Iva Uravić Bursać; Tatjana Kehler; Vedrana Drvar; Emina Babarović; Vesna Pehar Pejčinović; Antonija Ružić Baršić; Viktor Peršić; Gordana Laskarin
Journal:  Dis Markers       Date:  2022-06-03       Impact factor: 3.464

Review 2.  Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers.

Authors:  William Saalfeld; Amanda M Mixon; Jonna Zelie; Eileen J Lydon
Journal:  Rheumatol Ther       Date:  2021-09-14

Review 3.  The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis.

Authors:  Matteo Vecellio; Vivien Xanath Hake; Connor Davidson; Maria Cristina Carena; B Paul Wordsworth; Carlo Selmi
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

4.  Lumbar Canal Stenosis Caused by Spondylolisthesis and Intraspinal Canal Calcifications Associated with Psoriatic Arthritis: A Case Report.

Authors:  Hirotomo Tanaka; Yoshiyuki Takaishi; Jun Imura; Takashi Mizowaki; Keisuke Kobayashi; Takeshi Kondoh; Takashi Sasayama
Journal:  NMC Case Rep J       Date:  2021-11-19

5.  Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen-B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Authors:  Philip J Mease; Soumya D Chakravarty; Robert R McLean; Taylor Blachley; Toana Kawashima; Iris Lin; Arthur Kavanaugh; Alexis Ogdie
Journal:  ACR Open Rheumatol       Date:  2022-02-26

Review 6.  MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis.

Authors:  Francesca Motta; Andrea Pederzani; Maria Cristina Carena; Angela Ceribelli; Paul B Wordsworth; Maria De Santis; Carlo Selmi; Matteo Vecellio
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.